Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Rheincell Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Rheincell develops and manufactures GMP-grade human induced pluripotent stem cells (iPSCs) for the next generation of cell therapies. Our production pipeline focuses on high immune compatibility and low rejection potential, with a spotlight on solutions for off-the-shelf, allogenic therapeutics. To that end, we have constructed a unique business framework: exclusive access to clinically approved and consented cord blood cells,...
Rheincell develops and manufactures GMP-grade human induced pluripotent stem cells (iPSCs) for the next generation of cell therapies. Our production pipeline focuses on high immune compatibility and low rejection potential, with a spotlight on solutions for off-the-shelf, allogenic therapeutics. To that end, we have constructed a unique business framework: exclusive access to clinically approved and consented cord blood cells, proprietary cell reprogramming protocols, state-of-the-art clean room and cell culture facilities, GMP-compliant manufacturing processes, and a first-class community of iPSC workflow experts.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Rheincell Therapeutics
Germany Flag
Country
Country
Germany
Address
Address
Berghausener Strasse 98, 40764 Langenfeld (Rheinland)
Telephone
Telephone
+49.(0)2173.328 20
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY